Treatment of May-Thurner's Syndrome and Associated Complications: A Multicenter Experience
- PMID: 34447265
- PMCID: PMC8384425
- DOI: 10.2147/IJGM.S325231
Treatment of May-Thurner's Syndrome and Associated Complications: A Multicenter Experience
Abstract
Objective: To assess the treatment options and associated complications in patients with May-Thurner's syndrome (MTS).
Methods: We retrospectively reviewed the charts of patients diagnosed with MTS. Thorough review was completed and data relevant to methods of diagnosis, treatment, complications, hospital readmission, and mortality were extracted from patient charts. The patients were followed for two years after diagnosis.
Results: Of the 47 patients identified as having "MTS", 32 (70%) were diagnosed formally with either magnetic resonance venography, computed tomography venography, or ultrasound. Two patients were excluded for insufficient availability of follow-up records. Mean age of the population included (N = 30) was 50.24 ±15.33 years and 83% (N = 25) had female gender. The majority (40%) of patients were treated with anticoagulation, thrombolysis, and stent placement, and 13.3% received a combination of anticoagulation, antiplatelet agent, thrombolysis, and stent placement. Overall, we found 28 patients (93%) who underwent endovascular stenting. However, 39.3% (11/28) had stent-related complications that included stent thrombosis, stenosis, and migration. One patient underwent open heart surgery for stent retrieval. Duration of anticoagulation therapy ranged from 6 months to lifelong. Two patients (6.7%) suffered major bleeds requiring transfusion. Fourteen patients (46.6%) developed post-thrombotic syndrome. Seven (23.3%) patients required MTS-related readmission within 30 days. No mortality was noted at two-year follow-up.
Conclusion: Although our study only included 30 patients, it was evident to us that there is no consensus in the management of MTS. Furthermore, endovascular stenting, which has a major role in the management of MTS, has complication rates that hover close to 40%. Further research is needed to help develop a standardized evidence-based approach in the management of MTS that ensures a decreased risk of immediate and long-term complications.
Keywords: May–Thurner syndrome; anticoagulation; complications; diagnosis; treatment.
© 2021 Sigua-Arce et al.
Conflict of interest statement
The authors have no conflicts of interest regarding this work or the publication of this paper.
Similar articles
-
Treatment of Deep Vein Thrombosis in May-Thurner's Syndrome with a Novel Oral Anticoagulant: A Case Report.Int J Angiol. 2019 Dec;28(4):262-266. doi: 10.1055/s-0038-1661003. Epub 2018 Jun 20. Int J Angiol. 2019. PMID: 31787826 Free PMC article.
-
Contemporary outcomes after venography-guided treatment of patients with May-Thurner syndrome.J Vasc Surg Venous Lymphat Disord. 2017 Sep;5(5):667-676.e1. doi: 10.1016/j.jvsv.2017.02.009. Epub 2017 May 12. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28818219
-
Post-COVID-19 Vaccine Thromboembolic Complication in the Setting of Newly Diagnosed May-Thurner Syndrome.Cureus. 2024 Mar 7;16(3):e55746. doi: 10.7759/cureus.55746. eCollection 2024 Mar. Cureus. 2024. PMID: 38586737 Free PMC article.
-
A review into the management of May-Thurner syndrome in adolescents.J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1104-1110. doi: 10.1016/j.jvsv.2020.05.006. Epub 2020 May 28. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32474151
-
May-Thurner syndrome, a diagnosis to consider in young males with no risk factors: a case report and review of the literature.J Med Case Rep. 2021 Mar 19;15(1):141. doi: 10.1186/s13256-021-02730-8. J Med Case Rep. 2021. PMID: 33736685 Free PMC article. Review.
Cited by
-
Deep learning and radiomics-driven algorithm for automated identification of May-Thurner syndrome in Iliac CTV imaging.Front Med (Lausanne). 2025 Apr 29;12:1526144. doi: 10.3389/fmed.2025.1526144. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40365495 Free PMC article.
-
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE.J Thromb Haemost. 2022 Feb;20(2):366-374. doi: 10.1111/jth.15574. Epub 2021 Nov 8. J Thromb Haemost. 2022. PMID: 34714962 Free PMC article.
-
Seizures, deep vein thrombosis, and pulmonary emboli in a severe case of May-Thurner syndrome: a case report.J Med Case Rep. 2022 Nov 11;16(1):411. doi: 10.1186/s13256-022-03639-6. J Med Case Rep. 2022. PMID: 36357911 Free PMC article.
-
Familiar Disposition of May-Thurner Syndrome-A Case Series.Life (Basel). 2024 Feb 4;14(2):221. doi: 10.3390/life14020221. Life (Basel). 2024. PMID: 38398730 Free PMC article.
-
Management of May Thurner Syndrome in Pregnant Patients.J Cardiovasc Dev Dis. 2022 Nov 23;9(12):410. doi: 10.3390/jcdd9120410. J Cardiovasc Dev Dis. 2022. PMID: 36547407 Free PMC article.
References
-
- May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957;8:419–427. - PubMed
-
- Virchow R. Uber die Erweinterung kleiner Gafassee. Arch Path Anat. 1851;3:427.
-
- O’Sullivan GJ, Semba CP, Bittner CA, et al. Endovascular management of iliac vein compression (May-Thurner) syndrome. J Vasc Interv Radiol. 2000;11:823–836. - PubMed
-
- Thijs W, Rabe KF, Rosendaal FR, Middeldorp S. Predominance of left-sided deep vein thrombosis and body weight. J Thromb Haemost. 2010;8:2083–2084. - PubMed
LinkOut - more resources
Full Text Sources